investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Preclinical Evaluation of Crucell's Ad26 and Ad35, in Intravaginal Vaccination in Mouse Models
John Schiller
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Patricia Steeg
Molecular Biology of the Metastatic Phenotype
All cancers but non-melanoma skin cancer
Pathology
James D Marks
Antibody Research Technology Center
All cancers but non-melanoma skin cancer
Benjamin Raphael
Computational Approaches for Structural Variation Studies in Genomes
All cancers but non-melanoma skin cancer
Matthew D Scharff
Mismatch repair in V region mutation and isotype switching
All cancers but non-melanoma skin cancer
Brian A Cobb
Antigenic Carbohydrate Structure, Function, and Specificity
All cancers but non-melanoma skin cancer
Robert S. Dipaola
Cancer Institute of New Jersey - Cancer Center Support Grant
All cancers but non-melanoma skin cancer
Gregory A Lizee
Using the MHC class I cytoplasmic tail to control tumor Ag presentation by DCs
All cancers but non-melanoma skin cancer
Nicholas Restifo
Developing New Immunotherapies Based of CD4+ T Cells
All cancers but non-melanoma skin cancer
John Koren
Novel Combination Therapeutic Strategies to Ablate Resistance to Hsp90 Inhibitors
All cancers but non-melanoma skin cancer